Fusion tyrosine kinase NPM-ALK Deregulates MSH2 and suppresses DNA mismatch repair function novel insights into a potent oncoprotein
about
ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patientsThe pathobiology of the oncogenic tyrosine kinase NPM-ALK: a brief update.NPM-ALK mediates phosphorylation of MSH2 at tyrosine 238, creating a functional deficiency in MSH2 and the loss of mismatch repair.The potent oncogene NPM-ALK mediates malignant transformation of normal human CD4(+) T lymphocytes.The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability.
P2860
Fusion tyrosine kinase NPM-ALK Deregulates MSH2 and suppresses DNA mismatch repair function novel insights into a potent oncoprotein
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Fusion tyrosine kinase NPM-ALK ...... ghts into a potent oncoprotein
@ast
Fusion tyrosine kinase NPM-ALK ...... ghts into a potent oncoprotein
@en
type
label
Fusion tyrosine kinase NPM-ALK ...... ghts into a potent oncoprotein
@ast
Fusion tyrosine kinase NPM-ALK ...... ghts into a potent oncoprotein
@en
prefLabel
Fusion tyrosine kinase NPM-ALK ...... ghts into a potent oncoprotein
@ast
Fusion tyrosine kinase NPM-ALK ...... ghts into a potent oncoprotein
@en
P2093
P2860
P1476
Fusion tyrosine kinase NPM-ALK ...... ghts into a potent oncoprotein
@en
P2093
Benjamin A Adam
Jelena Holovati
Kathleen M Bone
Pascal Gelebart
Raymond Lai
Samar Hegazy
Susan E Andrew
P2860
P304
P356
10.1016/J.AJPATH.2011.03.045
P407
P50
P577
2011-05-24T00:00:00Z